These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23739335)

  • 21. NMR studies of p7 protein from hepatitis C virus.
    Cook GA; Opella SJ
    Eur Biophys J; 2010 Jun; 39(7):1097-104. PubMed ID: 19727701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.
    StGelais C; Foster TL; Verow M; Atkins E; Fishwick CW; Rowlands D; Harris M; Griffin S
    J Virol; 2009 Aug; 83(16):7970-81. PubMed ID: 19493992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
    Foster TL; Verow M; Wozniak AL; Bentham MJ; Thompson J; Atkins E; Weinman SA; Fishwick C; Foster R; Harris M; Griffin S
    Hepatology; 2011 Jul; 54(1):79-90. PubMed ID: 21520195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition.
    Ohigashi Y; Ma C; Jing X; Balannick V; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18775-9. PubMed ID: 19841275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapy.
    Shaw J; Gosain R; Kalita MM; Foster TL; Kankanala J; Mahato DR; Abas S; King BJ; Scott C; Brown E; Bentham MJ; Wetherill L; Bloy A; Samson A; Harris M; Mankouri J; Rowlands DJ; Macdonald A; Tarr AW; Fischer WB; Foster R; Griffin S
    Elife; 2020 Nov; 9():. PubMed ID: 33169665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.
    Griffin SDC; Harvey R; Clarke DS; Barclay WS; Harris M; Rowlands DJ
    J Gen Virol; 2004 Feb; 85(Pt 2):451-461. PubMed ID: 14769903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy.
    Cady SD; Wang J; Wu Y; DeGrado WF; Hong M
    J Am Chem Soc; 2011 Mar; 133(12):4274-84. PubMed ID: 21381693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the physiological relevance of alternate architectures of the p7 protein of hepatitis C virus in different environments.
    Holzmann N; Chipot C; Penin F; Dehez F
    Bioorg Med Chem; 2016 Oct; 24(20):4920-4927. PubMed ID: 27501910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses.
    Pielak RM; Oxenoid K; Chou JJ
    Structure; 2011 Nov; 19(11):1655-63. PubMed ID: 22078564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical Probes for Blocking of Influenza A M2 Wild-type and S31N Channels.
    Tzitzoglaki C; McGuire K; Lagarias P; Konstantinidi A; Hoffmann A; Fokina NA; Ma C; Papanastasiou IP; Schreiner PR; Vázquez S; Schmidtke M; Wang J; Busath DD; Kolocouris A
    ACS Chem Biol; 2020 Sep; 15(9):2331-2337. PubMed ID: 32786258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission.
    Meredith LW; Zitzmann N; McKeating JA
    Antiviral Res; 2013 Dec; 100(3):636-9. PubMed ID: 24157306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexistence of two adamantane binding sites in the influenza A M2 ion channel.
    Rosenberg MR; Casarotto MG
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13866-71. PubMed ID: 20643947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical Effect of the Detergent:Protein Ratio on the Formation of the Hepatitis C Virus p7 Channel.
    Chen W; OuYang B; Chou JJ
    Biochemistry; 2019 Sep; 58(37):3834-3837. PubMed ID: 31468972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system.
    StGelais C; Tuthill TJ; Clarke DS; Rowlands DJ; Harris M; Griffin S
    Antiviral Res; 2007 Oct; 76(1):48-58. PubMed ID: 17574688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adamantan derivatives capable of inhibiting the reproduction of a Rimantadine resistant strain of influenza A(H1N1)pdm09 virus (Influenza A virus, Alphainfluenzavirus, Orthomyxoviridae).].
    Garaev TM; Odnovorov AI; Kirillova ES; Burtseva EI; Finogenova MP; Mukasheva EA; Grebennikova TV
    Vopr Virusol; 2020; 65(1):16-20. PubMed ID: 32496716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetric dynamics of ion channel forming proteins - Hepatitis C virus (HCV) p7 bundles.
    Kalita MM; Fischer WB
    Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1462-70. PubMed ID: 27079148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
    Wang JF; Wei DQ; Chou KC
    Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paramagnetic Cu(II) for probing membrane protein structure and function: inhibition mechanism of the influenza M2 proton channel.
    Su Y; Hu F; Hong M
    J Am Chem Soc; 2012 May; 134(20):8693-702. PubMed ID: 22519936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case.
    Thomaston JL; Wu Y; Polizzi N; Liu L; Wang J; DeGrado WF
    J Am Chem Soc; 2019 Jul; 141(29):11481-11488. PubMed ID: 31184871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.